- Home
- JBTM vs HSIC Comparison
JBTM vs HSIC Comparison
Compare JBTM & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JBTM | HSIC |
|---|---|---|
| Founded | 1994 | 1932 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical Specialities |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 9.1B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | JBTM | HSIC |
|---|---|---|
| Price | $159.03 | $79.74 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 13 |
| Target Price | ★ $161.50 | $75.92 |
| AVG Volume (30 Days) | 458.8K | ★ 1.2M |
| Earning Date | 02-23-2026 | 02-24-2026 |
| Dividend Yield | ★ 0.25% | N/A |
| EPS Growth | N/A | ★ 30.70 |
| EPS | N/A | ★ 3.17 |
| Revenue | $3,257,800,000.00 | ★ $12,938,000,000.00 |
| Revenue This Year | $124.13 | $5.34 |
| Revenue Next Year | $4.45 | $3.42 |
| P/E Ratio | ★ N/A | $25.24 |
| Revenue Growth | ★ 92.43 | 3.51 |
| 52 Week Low | $90.08 | $60.56 |
| 52 Week High | $160.84 | $82.49 |
Technical Indicators
Market Signals| Indicator | JBTM | HSIC |
|---|---|---|
| Relative Strength Index (RSI) | 63.46 | 64.64 |
| Support Level | $154.58 | $74.90 |
| Resistance Level | $160.40 | $80.03 |
| Average True Range (ATR) | 3.67 | 1.91 |
| MACD | -0.15 | -0.07 |
| Stochastic Oscillator | 84.65 | 96.48 |
Price Performance
Historical ComparisonAbout JBTM JBT Marel Corporation
JBT Marel Corp is a technology solutions provider to segments of the food and beverage industry. It designs, produces, and services products and systems for a broad range of end markets, generating roughly one-half of annual revenue from recurring parts, services, rebuilds, and leasing operations.
About HSIC Henry Schein Inc.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.